Spain vs Germany: Two Models of Cannabis Regulation in Europe

The cannabis landscape in Europe is undergoing a radical transformation in 2025, with two diametrically opposed models illustrating the continent's different regulatory philosophies. While Germany is opting for broad legalization of recreational and medical use, Spain is implementing a restrictive, exclusively hospital-based framework for therapeutic purposes.

The German Model: Comprehensive Legalization

On April 1, 2024, Germany made history by becoming the most populous country in Europe to legalize recreational cannabis. The Cannabis Act (CanG) allows individuals over 18 to possess up to 25 grams in public spaces and 50 grams in private homes, in addition to growing up to three plants  for personal consumption.

As of July 1, 2024, Germany implemented a system of non-profit cannabis clubs, each with a maximum of 500 members. These spaces function as distribution points for collective harvests, although consumption within the clubs is prohibited.

The figures for the German market are impressive. The country imported approximately 72,000 kilograms of cannabis in 2024, more than double the previous year. The medical market is worth around 670 million euros annually and continues to grow exponentially, solidifying Germany's position as the undisputed leader in European cannabis.

The Conservative Spanish Approach

In contrast, Royal Decree 903/2025, approved in October, represents a historic advance for Spain, but maintains significant restrictions. Medical cannabis can only be prescribed by hospital specialists for specific pathologies when conventional treatments fail.

Dispensing is limited to hospital pharmacies, with no access in community pharmacies. Standardized master formulas must be prepared with registered preparations in the AEMPS, guaranteeing exact THC and CBD compositions.

This regulatory caution contrasts with the country's production reality. Spain cultivated 51.3 tons in 2024, with 100% destined for export, mainly to Germany and the United Kingdom. The Spanish sector has about 70 companies and nearly 500 employees, with GMP-certified pharmaceutical-grade facilities.

Social Clubs: The Spanish Paradox

Spain has more than 800 cannabis social clubs operating in a legal gray area, especially concentrated in Catalonia (over 200), the Basque Country (150), and Madrid (100). These spaces function as private associations where members share collective cultivation and consume in closed facilities.

Paradoxically, Germany was inspired by the Spanish club model for its recreational regulation, while in Spain these spaces continue to face administrative penalties, making the country the one that most penalizes cannabis use in Europe, according to the European Monitoring Centre for Drugs and Drug Addiction.

Home Cultivation: Different Philosophies

In Germany, home cultivation has been fully legal since April 2024, with up to three plants allowed simultaneously. Growers can possess their harvest at home without strict limits as long as they maintain legal possession quantities.

In Spain, home cultivation remains in a legal limbo. The practice is tolerated if carried out privately for personal consumption and without visibility from public spaces, but it can lead to administrative penalties of up to 30,000 euros. The Criminal Code punishes cultivation with the intention of trafficking, although it does not establish a specific number of plants.

Economic Impact and Outlook

The German cannabis market is estimated at 670 million euros for 2025 solely in the medical field, with projections of continuous growth as pilot projects for recreational sales are implemented in cities like Berlin and Frankfurt.

Spain, for its part, could generate an internal market of between 250 and 400 million euros annually if it expands its regulation. Businessmen in the sector, such as Borja Iribarne from ProfesorCBD, estimate that comprehensive regulation could create 20,000 jobs and generate 500 million in taxes.

Cannabis Tourism: Barcelona vs. Berlin

Barcelona has established itself as one of the favorite destinations for European cannabis tourism, offering access to private clubs through membership. Tourists can join associations with prior recommendation, paying monthly fees of 20-50 euros.

Berlin, on the other hand, offers more direct access for German residents, although tourists cannot join cannabis clubs as it requires permanent residency in the country. Pilot projects for sales in specialized stores starting in 2025 could change this dynamic.

Lessons and Future

The comparison between both models highlights two distinct regulatory philosophies. Germany aims to normalize adult consumption with quality controls and prevention, while Spain prioritizes a restrictive medical-hospital approach.

The German experience demonstrates that regulation can create social order and economic benefits without increasing problematic consumption among minors. Spain, while observing these results, maintains a robust export sector but a nascent domestic market, facing the paradox of producing pharmaceutical-grade cannabis that its own citizens cannot easily access.

Time will tell if Spain will follow the German path towards broader regulation or maintain its conservative hospital approach, but social pressure and economic evidence point towards an inevitable expansion of the legal framework in the coming years.